A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2007
12/05/2007	EP0931149B1 A novel haemopoietin receptor and genetic sequences encoding same
12/05/2007	EP0760675B2 Compositions comprising dna damaging agents and p53
12/05/2007	CN101084509A Methods of identifying and designing cell surface receptor inhibitors
12/05/2007	CN101083980A Use of targeted oxidative therapeutic formulation in treatment of cancer
12/05/2007	CN101081300A Long-acting anti-parasite medicine injection
12/05/2007	CN101081224A Stable extended release oral dosage composition
12/05/2007	CN101081212A Protease inhibitors liposomes aerosol
12/05/2007	CN101081211A Water indissoluble carbostyrile compound injection and method for preparing the same
12/05/2007	CN101081209A Anticancer composition containing tyrosine kinase restraining agent and taxane
12/05/2007	CN101081208A Slow-release injection containing tyrosine kinase restraining agent and platinum compound
12/05/2007	CN101081207A Medicine composition containing tyrosine kinase restraining agent
12/05/2007	CN101081206A Anti-cancer medicine composition containing tyrosine kinase restraining agent
12/05/2007	CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis
12/05/2007	CN100352510C Therapeutically useful triethyleneglycol cholesteryl oligonucleotides
12/05/2007	CN100352507C Osmotic pump controlled release formulation containing two active constituents of medicine and process for preparing the same
12/05/2007	CN100352506C Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents
12/05/2007	CN100352505C A combination of FBPase Inhibitors and insulin sensitizers for the treatment of diabetes
12/05/2007	CN100352504C Nutritious supplementing agent contg. a-glucosidase inhibitor and a-amylase inhibitor
12/05/2007	CN100352503C Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
12/05/2007	CN100352494C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor
12/05/2007	CN100352448C Methods and compositions for the prevention of tolerance to medications
12/05/2007	CN100352446C Medicinal compositions comprising n-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide and further cytostatics
12/05/2007	CN100352442C Pharmaceutical combinations
12/05/2007	CN100352431C Pharmaceutical salts
12/05/2007	CN100352426C Method for preparing polymer micelle pharmaceutical preparation containing drug for injection
12/04/2007	US7304076 Dietetics; antidiabetic agents; eating disorders
12/04/2007	US7304068 Viricide against herpes virus; 3-(2-Fluoropyridin-4-yl)-2-phenyl-7-pyrrolidin-1-ylpyrazolo[1,5-a]pyrimidine; chemical synthesis
12/04/2007	US7304066 Pyridyl cyanoguanidine compounds
12/04/2007	US7304053 Glycoprotein-mediated MDR
12/04/2007	US7304035 Stimulation of bone growth with thrombin peptide derivatives
12/04/2007	US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
12/04/2007	US7304032 CD-10 activated prodrug compounds
12/04/2007	US7304029 Inducing a neuroprotective effect of rescuing neurons destined to degenerate or die as a result of hypoxia or ischemia in a brain of a patient by administering growth hormone centrally to the brain of the patient
12/04/2007	US7303926 Causing necrosis or apoptosis of target tissue using both type 1 and type 2 mechanisms
12/04/2007	US7303896 Nucleic acid encoding novel type-1 cytokine receptor GLM-R
12/04/2007	US7303895 Choline transport like (CTL) membrane proteins involved in choline transport
12/04/2007	US7303889 Ligand for G-protein coupled receptor GPR43 and uses thereof
12/04/2007	US7303765 Ultrafine-L-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
12/04/2007	US7303761 Stabilised pharmaceutical composition comprising an extended release non-steroidal anti-inflammatory agent and an immediate release prostaglandin
12/04/2007	US7303755 Use of sodium and potassium salts of citric, phosphoric, carbonic and tartaric acid and arginine and lysine as stabilizer of the antibiotic Fosfomycin Tromethamine
12/04/2007	US7303745 Method for preventing or treating the development of respiratory allergies
12/04/2007	US7302913 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells
12/04/2007	CA2283295C Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels
12/04/2007	CA2262647C Methods for regulating gastrointestinal motility
12/04/2007	CA2255891C Compositions and methods for treating or preventing diseases of body passageways
12/04/2007	CA2140878C Interleukin-4 stimulated t lymphocyte cell death
11/2007
11/29/2007	WO2007137167A2 Co-therapy for the treatment of epilepsy
11/29/2007	WO2007137164A2 Co-therapy for the treatment of epilepsy and related disorders
11/29/2007	WO2007137000A2 Combination cancer chemotherapy
11/29/2007	WO2007136696A2 Use of substituted azetidinone compounds with cetp inhibitors for the treatment of sitosterolemia
11/29/2007	WO2007136134A1 Process for producing polymer micelle enclosing hydrophobic drug
11/29/2007	WO2007135547A2 Selective estrogen receptor modulators or aromatase inhibitors for treating chronic nonbacterial prostatitis
11/29/2007	WO2007135518A2 Use of choline-based preparations for the treatment of tinnitus
11/29/2007	WO2007135387A1 Inhibitor of adenylyl cyclase for treating a disorder of the circadian rhythm
11/29/2007	WO2007115620A3 Novel cyclobutyl compounds as kinase inhibitors
11/29/2007	WO2007115287A3 Combination of organic compounds
11/29/2007	WO2007073888A3 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same
11/29/2007	WO2007056324A3 Combination of an angiotensin ii receptor blocker, a calcium channel blocker and another active agent
11/29/2007	WO2007050379A3 Preventing bacterial or viral infectivity and composition containing infection preventing additive
11/29/2007	WO2007038453A3 Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation
11/29/2007	WO2005009352A3 Antimicrobial compositons containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof
11/29/2007	WO2004078022A3 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
11/29/2007	WO2002028345A3 Aldehyde-releasing compounds
11/29/2007	US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007	US20070276040 Peptidyl Arginine Deiminase Type IV Inhibitor
11/29/2007	US20070276039 Pharmaceutical uses for alpha2delta ligands
11/29/2007	US20070276029 Glutamine-Containing Energy Imparting Amino Acid Composition or Amino Acid Solution
11/29/2007	US20070275993 Combinations Of An Anti Emetic Agent And An Enkephalinase Inhibitor
11/29/2007	US20070275912 Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase
11/29/2007	US20070275887 Method of Inhibiting Secretase Activity
11/29/2007	US20070275102 Method of affecting sleep and sleep-related behaviors
11/29/2007	US20070275006 Iridoid glycoside composition
11/29/2007	US20070274997 Compositions and Methods for Herpes Simplex Prophylaxis and Treatment
11/29/2007	US20070274986 Compositions comprising anti-CCR5 antibody
11/29/2007	US20070274953 Photochemical internalization for delivery of molecules into the cytosol
11/29/2007	DE68907430C5 Cytotoxische Therapie. Cytotoxic therapy.
11/29/2007	DE10259834B4 Test und Screeningverfahren zur Identifizierung von Inhibitoren von Beta-Sekretasen Test and screening methods for identifying inhibitors of beta secretases
11/29/2007	CA2652783A1 Selective estrogen receptor modulators or aromatase inhibitors for treating chronic nonbacterial prostatitis
11/29/2007	CA2652768A1 Inhibitors of progastrin-induced repression of icat for treating and/or preventing colorectal cancer, adenomatous polyposis or metastasis displaying progastrin-secreting cells andcells in which the beta-catenin/tcf-4-mediated transcriptional pathway is constitutively active
11/29/2007	CA2640671A1 Engineered antibody-stress protein fusions
11/28/2007	EP1860185A1 Screening method
11/28/2007	EP1859808A1 Novel sugar uptake activator and method for screening the same
11/28/2007	EP1859806A1 Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen
11/28/2007	EP1859804A1 Anticancer agent to be combined with telomelysin
11/28/2007	EP1859802A2 Compositions comprising benzo(G)quinoline derivates and prostaglandin derivates
11/28/2007	EP1859797A1 Novel concomitant use of sulfonamide compound with anti-cancer agent
11/28/2007	EP1859796A2 Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
11/28/2007	EP1859795A1 Therapeutic agent for ophthalmic disease
11/28/2007	EP1859793A1 Novel combinational use of sulfonamide compound
11/28/2007	EP1858923A1 A molecule and chimeric molecules thereof
11/28/2007	EP1858554A2 New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
11/28/2007	EP1858553A2 Methods of decreasing calcification
11/28/2007	EP1858507A2 Polyphenol coxib combinations and methods
11/28/2007	EP1858482A2 Methods of reducing microbial contamination
11/28/2007	EP1858481A1 Ophthalmologic compositions and use mode thereof
11/28/2007	EP1592447B1 Devices and compositions containing boron and silicon for use in neutron capture therapy
11/28/2007	EP1553909A4 Quick dissolve compositions and tablets based thereon
11/28/2007	EP1383912A4 Pd-1, a receptor for b7-4, and uses therefor
11/28/2007	EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007	EP1333832B1 Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors

1 ... 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 ... 1151